US green light for Medtronic cobalt stent:
This article was originally published in Clinica
Executive Summary
Medtronic today (October 2 2003) received FDA approval to market its Driver coronary stent in the US. The premarket approval (PMA) covers use of the stent for improving coronary luminal diameter in patients with de novo or restenotic lesions in vessels with diameters of 3-4mm, and less than or equal to 30mm in length. It is made of a cobalt-based alloy, allowing thinner struts than steel equivalents. The Driver stent is already in use in Europe where it has 29% market share for vessels 3mm and above, making it the leading cobalt alloy stent in Europe, according to Medtronic.
You may also be interested in...
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.